glp-1 receptor gene Targeted in vivo integration of a secretion-enabled agonist reverses diet-induced non-genetic obesity and pre-diabetes PDB-101: Diabetes Mellitus: Diabetes Mellitus:

DIO2, which encodes an enzyme involved in thyroid hormone metabolism, has been associated with abnormal brain development and behavioral changes when overexpressed [17]

Decreased hepatic glycogen content has been shown in preclinical models to contribute to insulin resistance and hepatic steatosis, two physiologic states directly implicated in diseases of metabolic dysfunction such as T2DM and obesity [94]

This could include: Heart rate assessment at 4-8 weeks after initiation or dose escalation Periodic electrocardiography if arrhythmias are suspected Patient self-monitoring of pulse if symptomatic palpitations occur Evaluation of heart rate control in patients with atrial fibrillation When evaluating tachycardia in patients on GLP-1 therapy, clinicians should assess for other potential causes, including dehydration (especially from GI side effects), anemia, hyperthyroidism, stimulant use, infection, or other medications

The study authors caution that Reddit users are not representative of the general population

The semaglutide group actually showed increases in load-bearing bone volume